{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:11:29Z","timestamp":1792289489139,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008390","name":"Forskerakademiet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["0208-00018B"],"award-info":[{"award-number":["0208-00018B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008389","name":"Danish Ministry of Education and Science","doi-asserted-by":"publisher","award":["0238-00001B"],"award-info":[{"award-number":["0238-00001B"]}],"id":[{"id":"10.13039\/100008389","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ebiom.2021.103410","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T17:04:46Z","timestamp":1622826286000},"page":"103410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3313-5900","authenticated-orcid":false,"given":"Stine SF","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8945-1905","authenticated-orcid":false,"given":"Line K","family":"Vibholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Monrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7765-6428","authenticated-orcid":false,"given":"Giacomo S","family":"Frattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie H","family":"Pahus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper F","family":"H\u00f8jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3787-0259","authenticated-orcid":false,"given":"Jesper D","family":"Gunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Erikstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Holleufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1159-066X","authenticated-orcid":false,"given":"Rune","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole S","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane H","family":"Schleimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Tolstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7798","key":"10.1016\/j.ebiom.2021.103410_bib0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103410_bib0002","series-title":"Coronavirus Disease 2019 (COVID-19) Situation Report 51. Who.int","year":"2021"},{"key":"10.1016\/j.ebiom.2021.103410_bib0003","series-title":"Coronavirus disease (COVID-19) situation reports, Weekly Epidemiological Update -23 February 2021","year":"2021"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103410_bib0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103410_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103410_bib0006","series-title":"Features, Evaluation, and Treatment of Coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"10.1016\/j.ebiom.2021.103410_bib0007","series-title":"Newsroom - 172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility","year":"2020"},{"issue":"27","key":"10.1016\/j.ebiom.2021.103410_bib0008","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103410_bib0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"issue":"10269","key":"10.1016\/j.ebiom.2021.103410_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet North Am Ed"},{"issue":"24","key":"10.1016\/j.ebiom.2021.103410_bib0011","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1\u20132 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N Engl J Med"},{"issue":"10275","key":"10.1016\/j.ebiom.2021.103410_bib0012","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ebiom.2021.103410_bib0013","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim Results of a Phase 1\u20132a Trial of Ad26.COV2.S Covid-19 Vaccine","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103410_bib0014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/jiaa273","article-title":"Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019","volume":"222","author":"Burbelo","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103410_bib0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2026116","article-title":"Humoral Immune Response to SARS-CoV-2 in Iceland","author":"Gudbjartsson","year":"2020","journal-title":"NEJM"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103410_bib0016","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1038\/s41467-020-18178-1","article-title":"Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak","volume":"11","author":"Dingens","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2021.103410_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa489","article-title":"Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","author":"Qu","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7815","key":"10.1016\/j.ebiom.2021.103410_bib0018","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103410_bib0019","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications","author":"Wu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ebiom.2021.103410_bib0020","first-page":"eabc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2021.103410_bib0021","article-title":"Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing","author":"To","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103410_bib0022","article-title":"Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain","author":"Van Elslande","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103410_bib0023","article-title":"Genomic evidence for reinfection with SARS-CoV-2: a case study","author":"Tillett","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103410_bib0024","unstructured":"Iwasaki A. What reinfections mean for COVID-19. The Lancet Infectious Diseases."},{"issue":"6505","key":"10.1016\/j.ebiom.2021.103410_bib0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2021.103410_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","author":"Sekine","year":"2020","journal-title":"Cell"},{"issue":"7821","key":"10.1016\/j.ebiom.2021.103410_bib0027","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103410_bib0028","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-020-00263-y","article-title":"Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.ebiom.2021.103410_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104572","article-title":"Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2","volume":"130","author":"Johnson","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ebiom.2021.103410_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103230","article-title":"SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses","volume":"64","author":"Vibholm","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103410_bib0031","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1038\/s41467-020-17317-y","article-title":"An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment","volume":"11","author":"GeurtsvanKessel","year":"2020","journal-title":"Nat Commun"},{"issue":"Pt 5","key":"10.1016\/j.ebiom.2021.103410_bib0032","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1099\/vir.0.80788-0","article-title":"Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes","volume":"86","author":"Hanika","year":"2005","journal-title":"J Gen Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103410_bib0033","doi-asserted-by":"crossref","first-page":"e25858","DOI":"10.1371\/journal.pone.0025858","article-title":"A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon","volume":"6","author":"Berger Rentsch","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103410_bib0034","doi-asserted-by":"crossref","first-page":"e72942","DOI":"10.1371\/journal.pone.0072942","article-title":"Differential Sensitivity of Bat Cells to Infection by Enveloped RNA Viruses: Coronaviruses, Paramyxoviruses, Filoviruses, and Influenza Viruses","volume":"8","author":"Hoffmann","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103410_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2119\/molmed.2015.00031","article-title":"Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir","volume":"21","author":"H\u00f8jen","year":"2015","journal-title":"Molecular Medicine (Cambridge, Mass)"},{"issue":"7821","key":"10.1016\/j.ebiom.2021.103410_bib0036","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103410_bib0037","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103410_bib0038","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"7819","key":"10.1016\/j.ebiom.2021.103410_bib0039","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103410_bib0040","doi-asserted-by":"crossref","first-page":"408-","DOI":"10.1038\/s41577-020-0362-x","article-title":"SARS-CoV-2 cross-reactivity in healthy donors","volume":"20","author":"van der","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"52","key":"10.1016\/j.ebiom.2021.103410_bib0041","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe0367","article-title":"Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients","volume":"5","author":"Iyer","year":"2020","journal-title":"Science Immunology"},{"key":"10.1016\/j.ebiom.2021.103410_bib0042","first-page":"eabd3871","article-title":"Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans","author":"Mateus","year":"2020","journal-title":"Science"},{"issue":"1880","key":"10.1016\/j.ebiom.2021.103410_bib0043","article-title":"The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development","volume":"11","author":"Alturki","year":"2020","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.ebiom.2021.103410_bib0044","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"issue":"7830","key":"10.1016\/j.ebiom.2021.103410_bib0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103410_bib0046","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103410_bib0047","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clim.2006.05.002","article-title":"Long-lived effector\/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients","volume":"120","author":"Yang","year":"2006","journal-title":"Clinical immunology (Orlando, Fla)"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103410_bib0048","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study","volume":"186","author":"Tang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2021.103410_bib0049","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","author":"Peng","year":"2020","journal-title":"Nat Immunol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421002036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421002036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:05:50Z","timestamp":1762455950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421002036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":49,"alternative-id":["S2352396421002036"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103410","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.08.331645","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103410"}}